Covid-19 roundup: Junshi, Eli Lilly ready to launch Covid-19 antibody trial; Janet Woodcock steps aside — for now — as FDA drug czar
Junshi Biosciences and their partners at Eli Lilly say they’re on track to launch the first human trial of a new antibody aimed at fighting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
